Gerresheimer AG
XETRA:GXI
Gerresheimer AG
Total Liabilities & Equity
Gerresheimer AG
Total Liabilities & Equity Peer Comparison
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Gerresheimer AG
XETRA:GXI
|
Total Liabilities & Equity
€3.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
|
E
|
Evotec SE
XETRA:EVT
|
Total Liabilities & Equity
€2.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
20%
|
CAGR 10-Years
26%
|
S
|
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
|
Total Liabilities & Equity
€1.2B
|
CAGR 3-Years
27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Gerresheimer AG's Total Liabilities & Equity?
Total Liabilities & Equity
3.5B
EUR
Based on the financial report for Feb 29, 2024, Gerresheimer AG's Total Liabilities & Equity amounts to 3.5B EUR.
What is Gerresheimer AG's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
8%
Over the last year, the Total Liabilities & Equity growth was 6%. The average annual Total Liabilities & Equity growth rates for Gerresheimer AG have been 10% over the past three years , 5% over the past five years , and 8% over the past ten years .